Comparison of long-term outcomes of infliximab and adalimumab therapy in biologic-naive patients with ulcerative colitis
Our results hint at the likelihood of IFX and ADA presenting similar clinical outcomes as first-time agents in UC. Nonetheless, the need for steroids with ADA should be taken into consideration.
Authors
- İlhami Yüksel (ORCID: https://orcid.org/0000-0002-9730-2309)
- Muhammed Bahaddin Durak (ORCID: https://orcid.org/0000-0001-8389-8191)
- Yavuz Çağır (ORCID: https://orcid.org/0000-0002-5676-9914)
Institutions
- Memorial Ankara Hospital (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- Saudi Journal of Gastroenterology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.4103/sjg.sjg_180_24
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.10